NCT00518869 2025-06-04
Complementary Treatment of PG2 to Improve Clinical Benefit Response and Quality of Life in Fatigue
PhytoHealth Corporation
Phase 2/3 Terminated
PhytoHealth Corporation
Teva Branded Pharmaceutical Products R&D, Inc.
Meriyana Bio Inc.